First Midwest Bank Trust Division’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,547
Closed -$2.1M 383
2021
Q2
$2.1M Sell
24,547
-1,032
-4% -$55.3K 0.28% 88
2021
Q1
$1.15M Sell
25,579
-134,299
-84% -$5.28M 0.16% 151
2020
Q4
$1.09M Buy
159,878
+3,566
+2% +$31.8K 0.16% 145
2020
Q3
$1.8M Buy
+156,312
New +$705K 0.28% 90

Other funds holding FLNA

First Midwest Bank Trust Division's FLNA Position: Q3 2021 in Review

First Midwest Bank Trust Division sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 24,547 shares — an estimated $2.1M sold.

First Midwest Bank Trust Division first reported a position in FLNA in Q3 2020 and held it in 4 quarters. The position peaked at $2.1M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

  • First Midwest Bank Trust Division reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 24,547 Filana Therapeutics shares in Q3 2021, an estimated $2.1M.
  • First Midwest Bank Trust Division first reported a position in Filana Therapeutics in Q3 2020 and held it in 4 quarters.
  • First Midwest Bank Trust Division's Filana Therapeutics position peaked at $2.1M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q3 2021, filed 12 Oct 2021.